Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Maharasnadi Kwath is a traditional Ayurvedic polyherbal formulation primarily used for the management of musculoskeletal and neurological disorders associated with Vata imbalance. The formulation is based on a decoction of approximately 26 medicinal herbs, with *Pluchea lanceolata* (Rasna) serving as the primary active ingredient. It is widely utilized for its potent anti-inflammatory, analgesic, and anti-rheumatic properties. The drug works by modulating pro-inflammatory cytokines and providing neuroprotective effects, making it a standard treatment in Ayurvedic practice for conditions such as rheumatoid arthritis, osteoarthritis, sciatica, hemiplegia, and various neuralgias. It is often co-administered with Guggulu to enhance its therapeutic efficacy in joint disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Maharasnadi Kwath.